IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CAPRIOLI, FLAVIO ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.318
AS - Asia 12.754
NA - Nord America 12.672
SA - Sud America 1.390
AF - Africa 318
OC - Oceania 91
Continente sconosciuto - Info sul continente non disponibili 9
Totale 42.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.154
GB - Regno Unito 4.070
CN - Cina 3.923
IT - Italia 3.743
SG - Singapore 3.604
DE - Germania 2.315
HK - Hong Kong 1.076
BR - Brasile 1.060
BD - Bangladesh 1.019
RU - Federazione Russa 984
SE - Svezia 934
VN - Vietnam 737
FR - Francia 709
IN - India 651
NL - Olanda 484
JP - Giappone 380
CA - Canada 334
IE - Irlanda 322
KR - Corea 321
FI - Finlandia 319
TR - Turchia 316
UA - Ucraina 261
ES - Italia 234
PL - Polonia 227
ID - Indonesia 193
DK - Danimarca 177
EU - Europa 122
CO - Colombia 110
CI - Costa d'Avorio 99
MX - Messico 98
AR - Argentina 97
AT - Austria 79
AU - Australia 74
BE - Belgio 73
GR - Grecia 61
CH - Svizzera 57
PT - Portogallo 55
ZA - Sudafrica 55
TW - Taiwan 54
IL - Israele 46
IQ - Iraq 45
EG - Egitto 44
PK - Pakistan 41
MY - Malesia 40
IR - Iran 38
PH - Filippine 38
SA - Arabia Saudita 37
CZ - Repubblica Ceca 34
TH - Thailandia 34
RO - Romania 30
EC - Ecuador 28
HU - Ungheria 28
VE - Venezuela 25
CL - Cile 23
JO - Giordania 23
MA - Marocco 23
NO - Norvegia 22
PE - Perù 22
UZ - Uzbekistan 22
AE - Emirati Arabi Uniti 19
KZ - Kazakistan 18
TN - Tunisia 17
KE - Kenya 15
LU - Lussemburgo 15
NZ - Nuova Zelanda 15
CR - Costa Rica 14
DZ - Algeria 14
LT - Lituania 14
JM - Giamaica 13
ET - Etiopia 12
RS - Serbia 11
TT - Trinidad e Tobago 11
AL - Albania 10
AZ - Azerbaigian 10
BG - Bulgaria 10
PY - Paraguay 10
SK - Slovacchia (Repubblica Slovacca) 9
BO - Bolivia 8
GT - Guatemala 7
LB - Libano 7
LK - Sri Lanka 7
MO - Macao, regione amministrativa speciale della Cina 7
NI - Nicaragua 7
SI - Slovenia 7
SV - El Salvador 7
BB - Barbados 6
GE - Georgia 6
KW - Kuwait 6
LV - Lettonia 6
NP - Nepal 6
OM - Oman 6
SC - Seychelles 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
HR - Croazia 5
MK - Macedonia 5
AO - Angola 4
GH - Ghana 4
NG - Nigeria 4
BS - Bahamas 3
Totale 42.596
Salva come PNG Salva come JPEG
Città #
Southend 3.608
Singapore 2.042
Ashburn 1.388
Milan 1.051
Hong Kong 925
Frankfurt am Main 815
Chandler 792
San Jose 736
Dallas 725
Hanover 607
Beijing 556
Seattle 477
Santa Clara 449
Council Bluffs 438
Los Angeles 383
Hefei 356
Wilmington 352
Fairfield 349
Princeton 340
Dublin 315
Ann Arbor 308
New York 300
Rome 251
Bengaluru 244
Ho Chi Minh City 215
Lauterbourg 210
Woodbridge 205
Houston 201
Jacksonville 194
Boardman 191
Buffalo 190
Hanoi 189
Nanjing 189
Shanghai 188
Warsaw 182
Guangzhou 168
Helsinki 158
Moscow 158
Tokyo 149
Dearborn 148
Cambridge 143
Des Moines 137
Jakarta 134
Toronto 128
São Paulo 127
Redwood City 117
Redmond 108
Cinisello Balsamo 104
Chicago 103
Munich 101
Abidjan 99
Somerville 98
Mantova 92
Mountain View 87
Seoul 87
Turin 86
Columbus 83
Shenyang 81
Phoenix 80
Serra 73
The Dalles 73
Berlin 72
Sakarya 72
Tianjin 71
Bogotá 70
Nuremberg 70
Cangzhou 68
Hangzhou 67
Andover 66
London 66
Shenzhen 63
Naples 62
Jinan 61
Madrid 59
Nanchang 59
Changsha 57
Paris 57
Atlanta 55
Florence 55
Margão 55
Bologna 51
Istanbul 50
Montreal 50
Grafing 47
Brooklyn 44
Amsterdam 43
Washington 43
Brussels 42
San Diego 42
Palermo 41
Mumbai 40
Vienna 37
Athens 36
Belo Horizonte 36
Chennai 35
Hebei 35
Bari 34
Wuhan 34
Da Nang 33
Orem 33
Totale 24.894
Salva come PNG Salva come JPEG
Nome #
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors 1.530
Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection 713
Pathogenicity of in-vivo generated intestinal Th17 lymphocytes is IFNγ dependent 544
A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis 507
Diagnostic interobserver variability in Crohn's disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group 446
Intestinal IFN-γ–producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease 433
Outcomes of COVID-19 in 79 patients with IBD in Italy : an IG-IBD study 429
Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells 402
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue 382
Follistatin-like protein 1 sustains colon cancer cell growth and survival 382
Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy 368
Mucosa-associated microbiota drives pathogenic functions in IBD-derived intestinal iNKT cells 364
DIETARY IRON OVERLOAD INDUCES VISCERAL ADIPOSE TISSUE INSULIN RESISTANCE: SYNERGY WITH OBESITY IN INDUCING SYSTEMIC INSULIN RESISTANCE 356
Cell Blood Count Alterations and Patterns of Anaemia in Autoimmune Atrophic Gastritis at Diagnosis: A Multicentre Study 351
Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses 350
Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells 350
A gut-vascular barrier controls the systemic dissemination of bacteria 343
Fecal Microbiota Transplantation Controls Murine Chronic Intestinal Inflammation by Modulating Immune Cell Functions and Gut Microbiota Composition 340
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis 328
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 325
Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin 315
Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive Escherichia coli (AIEC) Virulence and Hamper IL-23/Th17 Axis in Ulcerative Colitis, but Not in Crohn's Disease 308
Short-term Oral Antibiotics Treatment Promotes Inflammatory Activation of Colonic Invariant Natural Killer T and Conventional CD4+T Cells 298
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus 293
An intestinal Th17 subset is associated with inflammation in Crohn's Disease and activated by adherent-invasive Escherichia coli (AIEC) 292
iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis 290
Using Robotic Systems to Process and Embed Colonic Murine Samples for Histological Analyses 283
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 280
Milan Ultrasound Criteria are accurate in assessing disease activity in ulcerative colitis: External validation 278
Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models 276
Reduction of CD68(+) macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy 272
Blood Bacterial DNA Load and Profiling Differ in Colorectal Cancer Patients Compared to Tumor-Free Controls 272
Superior predictive value of transmural over endoscopic severity for colectomy risk in ulcerative colitis: a multicenter prospective cohort study 262
Ultrasound elasticity imaging predicts therapeutic outcomes of patients with Crohn's disease treated with anti-tumour necrosis factor antibodies 262
Immunological variables associated with clinical and endoscopic response to vedolizumab in patients with inflammatory bowel diseases 261
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes 259
Drug-related pneumonitis in patients receiving Vedolizumab therapy for Inflammatory Bowel Disease 257
Previous colonic resection is a risk factor for surgical relapse in Crohn's disease 256
IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells 254
Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers 253
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 252
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin‐deficient mice 249
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study 244
Circulating ghrelin levels in patients with inflammatory bowel disease 237
Computer-assisted evaluation of perianal fistula activity by means of anal ultrasound in patients with Crohn's disease 235
Dietary iron overload induces visceral adipose tissue insulin resistance associated with hyper-resistinemia, and synergizes with obesity and fatty liver in inducing systemic insulin resistance 232
Surgery and diagnostic imaging in abdominal Crohn's disease 232
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 229
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan 228
Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C 227
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases 225
The role of ultrasound elasticity imaging in predicting ileal fibrosis in Crohn's disease patients 225
Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak 223
Plasma chromogranin A in patients with inflammatory bowel disease 222
The Bowel-Associated Arthritis-Dermatosis Syndrome (BADAS): A Systematic Review 221
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease 217
Circulating ghrelin levels in patients with inflammatory bowel diseases 217
Dietary iron overload induces visceral adipose tissue insulin resistance associated with hyper-resistinemia, and synergizes with obesity in inducing systemic insulin resistance 217
Fegato e malattie infiammatorie croniche intestinali 215
Evolving roles of cross-sectional imaging in Crohn's disease 214
Mesenteric fat hypertrophy in ileal Crohn's disease : does it contribute to c-reactive protein production? 212
Outcome of transfusion-associated chronic hepatitis C depends on patient age at infection 211
Adrenal incidentalomas (AI) in patients with hereditary hemochromatosis (HH) 211
Adalimumab is safe and effective in re-inducing clinical remission after post-surgical relaps of Crohn’s disease : a case report 211
Nutrition in Patients with Inflammatory Bowel Diseases: A Narrative Review 211
Circulating ghrelin levels in patients with inflammatory bowel diseases 209
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability (Modern Pathology, (2020), 33, 7, (1398-1409), 10.1038/s41379-020-0497-0) 208
The CD4-centered universe of human T cell subsets 206
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study 205
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy 205
Mesenteric fat hypertrophy in ileal Crohn's disease : does it contribute to C-reactive protein production? 204
Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model 204
Determinants of patient trust in gastroenterology televisits: Results of machine learning analysis 204
ATP-Gated Ionotropic P2X7 Receptor Controls Follicular T Helper Cell Numbers in Peyer’s Patches to Promote Host-Microbiota Mutualism 200
TNF-blockade enhances T cell responses to TCR stimulation in peripheral blood while it inhibits inflammatory gene expression in target tissues 198
Disease patterns in late-onset ulcerative colitis : Results from the IG-IBD "AGED study" 197
AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn's disease is suppressed by rfaP and ybaT deletion 196
Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus 195
Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues 195
Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy 195
Anal ultrasound (AUS) in perianal Crohn's disease : computer-assisted evaluation of fistula activity 191
Anal ultrasound (AUS) in evaluating activity of perianal Crohn’s disease (CD) 190
CD4+ T helper cell plasticity in infection, inflammation, and autoimmunity 190
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease 189
Computer-assisted evaluation of perianal fistula activity with anal ultrasound in patients with Crohn’s disease 189
IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis 188
Decrease of IL-17 and Gm-Csf in intestinal mucosa of Ibd patients is associated with reduction of CD68+macrophages and clinical remission in response to anti-TNF Therapy 188
Lesional Accumulation of CD163-Expressing Cells in the Gut of Patients with Inflammatory Bowel Disease 188
IL10 secretion endows intestinal human iNKT cells with regulatory functions towards pathogenic T lymphocytes 187
Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation 185
Human intestinal and circulating invariant Natural Killer T cells are cytotoxic against colorectal cancer cells via the perforin-granzyme pathway 183
The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study 182
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3α, by gut epithelial cells 182
Malattia celiaca ed epatopatie 182
Anal ultrasound in evaluating activity of perianal Crohn’s disease 180
Incidence and clinical outcome of intersphincteric abscesses in patients with perianal Crohn's disease 179
T-cell-directed therapies in inflammatory bowel diseases 179
Liver Involvement in Celiac Disease and Immune-Mediated Diseases of the Small Bowel 178
Autocrine regulation of IL-21 production in human T lymphocytes 178
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial 177
Totale 27.087
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.914
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 0 0 0 0 0 0 207
2021/20223.032 229 136 117 241 208 209 344 191 372 373 161 451
2022/20233.198 306 281 250 347 359 511 99 164 341 77 252 211
2023/20243.722 195 289 268 278 665 225 312 265 161 234 366 464
2024/20256.453 336 673 253 510 547 319 375 663 337 677 630 1.133
2025/202615.661 1.374 1.181 1.542 1.125 1.294 863 1.606 842 1.765 1.079 1.573 1.417
Totale 44.272